Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The NIH transition notice about using “Super Intelligence” instead of “Artificial Intelligence” has been removed from the top of the page.
    Difference
    1%
    Check dated 2026-11-08T14:16:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page has shifted from a 403 error screen to a mostly blank ClinicalTrials.gov page shell; the study record content is not visible.
    Difference
    0.6%
    Check dated 2026-11-01T15:46:18.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that “Super Intelligence” (SI) is being used in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:33:21.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T21:00:37.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now shows revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T22:05:47.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study page for NCT04908189 now returns a 403 Forbidden page, replacing the previously visible trial details. The core content and study metadata that defined the record have been removed from the page in favor of the error screen.
    Difference
    19%
    Check dated 2026-09-20T20:42:15.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.